Neelam Malik
Overview
Explore the profile of Neelam Malik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malik N, Agnihotri S, Dhiman P
Cent Nerv Syst Agents Med Chem
. 2024 Apr;
25(1):56-67.
PMID: 38584543
Aim: The purpose of the current study was to explore the virtual library for the screening against Monoamine oxidase (MAO) isoforms. An in-house library of natural based ligands was docked...
2.
Goyal R, Mittal G, Khurana S, Malik N, Kumar V, Soni A, et al.
Curr Pharm Biotechnol
. 2023 Aug;
25(9):1132-1141.
PMID: 37649295
The neurodegeneration process begins in conjunction with the aging of the neurons. It manifests in different parts of the brain as Aβ plaques, neurofibrillary tangles, Lewy bodies, Pick bodies, and...
3.
Dhiman P, Malik N
Curr Med Chem
. 2023 Aug;
31(41):6826-6841.
PMID: 37605400
Stress is a critical factor in the etiology of inflammation and neurodegeneration. The risk factor for the majority of psychiatric disorders is oxidative stress-induced depression. Mitochondrial damage and oxidative stress...
4.
Malik N, Dhiman P
Curr Top Med Chem
. 2022 Apr;
22(18):1515-1529.
PMID: 35473545
P-coumaric acid is a common dietary polyphenol present in fruits, vegetables, and cereals in conjugated and free form. The toxicity profile of the drug is very low, and it exhibits...
5.
Dhiman P, Malik N, Khatkar A
Curr Drug Metab
. 2020 May;
PMID: 32357811
Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or
published elsewhere. Furthermore, any...
6.
Dhiman P, Malik N, Khatkar A
BMC Chem
. 2020 Feb;
14(1):12.
PMID: 32099971
Neurodegenerative disorders follow numerous pathological ways concerning overexpression of monoamine oxidase and formation of reactive oxygen species. The computational design of the piperine derivatives has given the significant MAO inhibitors...
7.
Malik N, Khatkar A, Dhiman P
Med Chem
. 2019 Oct;
16(5):643-653.
PMID: 31584375
Background: Xanthine oxidase (XO; EC 1.17.3.2) has been considered as a potent drug target for the cure and management of pathological conditions prevailing due to high levels of uric acid...
8.
Malik N, Dhiman P, Khatkar A
BMC Chem
. 2019 Aug;
13(1):71.
PMID: 31384818
Background: Xanthine oxidase is an important enzyme of purine catabolism pathway and has been associated directly in pathogenesis of gout and indirectly in many pathological conditions like cancer, diabetes and...
9.
Malik N, Dhiman P, Khatkar A
BMC Chem
. 2019 Aug;
13(1):53.
PMID: 31384801
Background: Hesperitin, a naturally occurring flavonoid was hybridized with phenolic acids to evaluate its potential to inhibit the activity of xanthine oxidase (XO), a key enzyme which catalyses xanthine to...
10.
Dhiman P, Malik N, Khatkar A
BMC Chem
. 2019 Aug;
13(1):38.
PMID: 31384786
Natural based inhibitors of monoamine oxidase are promising drug candidates for the treatment of several neurodegenerative and neuropsychological disorders including depression, anxiety, Parkinson's disease and Alzheimer's disease. In the present...